WEKO3
アイテム
Carbon Ion Radiotherapy for Hepatocellular Carcinoma (HCC)
https://repo.qst.go.jp/records/61938
https://repo.qst.go.jp/records/61938f76be819-d102-4c26-8a9c-54ed18cd566b
| Item type | 会議発表用資料 / Presentation(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2006-12-05 | |||||
| タイトル | ||||||
| タイトル | Carbon Ion Radiotherapy for Hepatocellular Carcinoma (HCC) | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
| 資源タイプ | conference object | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Katou, Hirotoshi
× Katou, Hirotoshi× Yasuda, Shigeo× Yamada, Shigeru× Hara, Ryusuke× Kano, Masayuki× Kamada, Tadashi× Mizoe, Junetsu× Tsujii, Hirohiko× 加藤 博敏× 安田 茂雄× 山田 滋× 原 竜介× 加野 将之× 鎌田 正× 溝江 純悦× 辻井 博彦 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | In Japan, HCC accounts for 95% of all primary liver cancers. Since 85% of the HCC incidence develops from cirrhosis of the liver, the underlying cause of advanced liver insufficiency, it is essential that HCC therapy should have a high degree of radicality to cure the target tumor and a low level of invasiveness to spare the liver tissue so as ensure its resistance to the subsequent treatment interventions. While the various therapies currently available all have their particular limitations, it is certainly no exaggeration to note that there has been no procedure so far that has both a high radicality and low invasiveness while also being effective against large cancers. | |||||
| 会議概要（会議名, 開催地, 会期, 主催者等） | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | NIRS-CNAO Joint Symposium on Carbon Ion Radiotherapy | |||||
| 発表年月日 | ||||||
| 日付 | 2006-11-28 | |||||
| 日付タイプ | Issued | |||||
